Apr 20, 2023 / 02:15PM GMT
Mike Matson - Needham & Company, LLC - Analyst
Good morning. Thanks for joining us at the 22nd annual Needham Healthcare Conference. I'm Mike Matson, and I lead the MedTech and diagnostics equity research team at Needham & Company. I'm pleased to introduce Surmodics.
Presenting from Surmodics today, we have CEO, Gary Maharaj; and CFO, Tim Arens. They're going to give a presentation on Surmodics, and then we should have some time for questions. (Conference Instructions)
So with that, I'll turn it over to Gary and Tim.
Tim Arens - Surmodics, Inc. - SVP of Finance & Information Technology & CFO
Thank you, Mike.
Gary Maharaj - Surmodics, Inc. - President & CEO
Thank you, Mike. Thank you all for joining us today. So just to bring your attention to our Safe Harbor statement, given the intrinsic inherent risks and profit probabilities of any of our forward-looking statements.
So let's talk about Surmodics. Surmodics, we're driven. Our mission is really to improve the detection
Surmodics Inc at Needham Healthcare Conference (Virtual) Transcript
Apr 20, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers